Mary Crutchfield
Psychiatric/Mental Health · Virginia Beach, VANPI 1366715112
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 456 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 456 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Tris Pharma Inc$931
- Otsuka America Pharmaceutical, Inc.$915
- Johnson & Johnson$780
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$557
- Neurocrine Biosciences, Inc.$461
- plus $3K from 19 others
What the payments were for
- Food & beverage$7,88599%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 95 | $1,174 |
| Tris Pharma Inc | 52 | $931 |
| Otsuka America Pharmaceutical, Inc. | 55 | $915 |
| Johnson & Johnson | 29 | $780 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $557 |
| Neurocrine Biosciences, Inc. | 25 | $461 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $450 |
| Alkermes, Inc. | 19 | $444 |
| Supernus Pharmaceuticals, Inc. | 31 | $355 |
| Corium, LLC | 13 | $270 |
| E.r. Squibb & Sons, L.L.C. | 16 | $269 |
| Lundbeck LLC | 14 | $245 |
| Teva Pharmaceuticals USA, Inc. | 8 | $180 |
| Neos Therapeutics, LP | 11 | $178 |
| Ironshore Pharmaceuticals Inc. | 7 | $135 |
| Axsome Therapeutics, Inc. | 5 | $121 |
| Sunovion Pharmaceuticals Inc. | 7 | $106 |
| Collegium Pharmaceutical, Inc. | 5 | $103 |
| Idorsia Pharmaceuticals US Inc | 4 | $74 |
| Lilly USA, LLC | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Merck | 2 | $32 |
| Almatica Pharma LLC | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,932 in reported general payments places this provider in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 14 | $2,612 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $1,704 |
| Olanzapine | 21 | $527 |
| Methylphenidate Hcl | 21 | $501 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $483 |
| Clonazepam | 29 | $449 |
| Escitalopram Oxalate | 21 | $351 |
| Gabapentin | 21 | $213 |
| Trazodone Hcl | 18 | $209 |
| Fluoxetine Hcl | 23 | $171 |
| Diazepam | 14 | $151 |
| Lamotrigine | 12 | $128 |
| Sertraline Hcl | 23 | $31 |
| Buspirone Hcl | 23 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $60 | $52721 claims |
| Almatica Pharma LLCSertraline Hcl | $20 | $3123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.
Other psychiatric/mental health in Virginia Beach
- Genise BinnsVirginia Beach$12K
- Edward EvardVirginia Beach$8K
- Trisha ParkerVirginia Beach$6K
- Justin RayChesapeake$127K
- Katia HallChesapeake$88K
- Christine GilmoreBedford$75K
- Sarah FaberNewport News$59K
- Kristine GarciaGlen Allen$46K
- Tonjanika BoydRichmond$40K
- Kirby PatmonRichmond$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.